Detalhe da pesquisa
1.
Expression III: patients' expectations and preferences regarding physician-patient relationship and clinical management-results of the international NOGGO/ENGOT-ov4-GCIG study in 1830 ovarian cancer patients from European countries.
Ann Oncol
; 29(4): 910-916, 2018 04 01.
Artigo
Inglês
| MEDLINE | ID: mdl-29415128
2.
Gemcitabine and capecitabine in previously anthracycline-treated metastatic breast cancer: a multicenter phase II study (SOLTI 0301 trial).
Ann Oncol
; 21(7): 1442-1447, 2010 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-19940004
3.
Prognostic value of hormonal receptors, p53, ki67 and HER2/neu expression in epithelial ovarian carcinoma.
Clin Transl Oncol
; 10(6): 367-71, 2008 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-18558584
4.
Correction to: Efficacy of fulvestrant in the treatment of postmenopausal women with endocrine-resistant advanced breast cancer in routine clinical practice.
Clin Transl Oncol
; 20(12): 1631-1632, 2018 12.
Artigo
Inglês
| MEDLINE | ID: mdl-30284231
5.
Efficacy of fulvestrant in the treatment of postmenopausal women with endocrine-resistant advanced breast cancer in routine clinical practice.
Clin Transl Oncol
; 20(7): 862-869, 2018 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-29178019
6.
Update in the management of ovarian and cervical carcinoma.
Clin Transl Oncol
; 9(7): 443-51, 2007 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-17652058
7.
Phase II trial of vinorelbine in patients with advanced and/or recurrent cervical carcinoma: an EORTC Gynaecological Cancer Cooperative Group Study.
Eur J Cancer
; 36(2): 194-9, 2000 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-10741277
8.
Combination of oral idarubicin and prednimustine in advanced breast cancer: a phase II study.
Eur J Cancer
; 33(2): 312-5, 1997 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-9135508
9.
Cisplatin, doxorubicin and ifosfamide in carcinosarcoma of the female genital tract. A phase II study of the European Organization for Research and Treatment of Cancer Gynaecological Cancer Group (EORTC 55923).
Eur J Cancer
; 39(4): 481-7, 2003 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-12751379
10.
A phase I/II study of paclitaxel plus cisplatin as first-line therapy for head and neck cancers: preliminary results.
Semin Oncol
; 22(6 Suppl 15): 50-4, 1995 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-8643971
11.
Dose-escalated paclitaxel in 1-hour infusion with a fixed dose of cisplatin in previously untreated advanced ovarian cancer: a phase II trial of the Spanish Group for Ovarian Cancer.
Semin Oncol
; 24(5 Suppl 15): S15-40-S15-43, 1997 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-9346221
12.
High-dose mitoxantrone and cyclophosphamide without stem cell support in high-risk and advanced solid tumors: a phase I trial.
Bone Marrow Transplant
; 27(2): 117-23, 2001 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-11281378
13.
Treatment of small cell lung cancer with a combination of VP16-213 and cyclophosphamide with cisplatin or radiotherapy.
Cancer Chemother Pharmacol
; 7(2-3): 181-6, 1982.
Artigo
Inglês
| MEDLINE | ID: mdl-6282481
14.
[Adjuvant chemotherapy in the treatment of pharyngolaryngeal cancers in advanced stages]. / Tratamiento quimioterápico adyuvante en carcinomas laringo-faríngeos en estadios avanzados.
An Otorrinolaringol Ibero Am
; 22(2): 179-96, 1995.
Artigo
Espanhol
| MEDLINE | ID: mdl-7778720
15.
Safety and efficacy of metronomic non-pegylated liposomal encapsulated doxorubicin in heavily pretreated advanced breast cancer patients.
Clin Transl Oncol
; 15(6): 467-71, 2013 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-23263907
16.
GEICO (Spanish Group for Investigation on Ovarian Cancer) treatment guidelines in ovarian cancer 2012.
Clin Transl Oncol
; 15(7): 509-25, 2013 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-23468275
17.
It is not time to stop progesterone receptor testing in breast cancer.
J Clin Oncol
; 23(16): 3868-9; author reply 3869-70, 2005 Jun 01.
Artigo
Inglês
| MEDLINE | ID: mdl-15923595
18.
Advanced ovarian cancer: phase III randomized study of sequential cisplatin-topotecan and carboplatin-paclitaxel vs carboplatin-paclitaxel.
J Natl Cancer Inst
; 102(20): 1547-56, 2010 Oct 20.
Artigo
Inglês
| MEDLINE | ID: mdl-20937992
19.
Efficacy of fulvestrant in the treatment of postmenopausal women with endocrine-resistant advanced breast cancer in routine clinical practice
Clin. transl. oncol. (Print)
; 20(7): 862-869, jul. 2018. tab, graf
Artigo
Inglês
| IBECS (Espanha) | ID: ibc-173637
20.
CA15-3 and alkaline phosphatase as predictors for breast cancer recurrence: a combined analysis of seven International Breast Cancer Study Group trials.
Ann Oncol
; 18(4): 701-8, 2007 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-17237474